Literature DB >> 29107311

The Use of Remifentanil as the Primary Agent for Analgesia in Parturients.

Bryan Anderson1.   

Abstract

Pain control in parturients can be particularly challenging for the hospital staff. To achieve optimal outcomes in anesthesia patients, it is important to consider multiple options for pain control, especially when traditional options pose a problem or are not options. In particular, there are parturient clients for whom the use of neuraxial anesthesia (epidural and spinal blockade) is not an option. One option that warrants consideration for patient centered anesthesia practice is the use of remifentanil.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analgesia in parturients; Obstetric analgesia; Opioids in pregnancy; Remifentanil; Ultiva

Mesh:

Substances:

Year:  2017        PMID: 29107311     DOI: 10.1016/j.cnc.2017.08.009

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  2 in total

1.  Pre- and during- labour predictors of dystocia in active phase of labour: a case-control study.

Authors:  Jila Nahaee; Fatemeh Abbas-Alizadeh; Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh-Charandabi
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-28       Impact factor: 3.007

2.  Remifentanil reduces glutamate toxicity in rat olfactory bulb neurons in culture.

Authors:  Muhammet Emin Naldan; Ali Taghizadehghalehjoughi
Journal:  Braz J Anesthesiol       Date:  2021-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.